Nexalin Technology Income Statement (2021-2026) | NXL

Income Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.06M0.02M0.32M0.41M0.55M0.04M0.03M0.04M0.02M0.02M0.08M0.03M0.04M0.03M0.04M0.07M0.02M0.17M0.01M
Cost of Revenue (Quarter) 0.01M-0.00M0.05M0.12M0.19M0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.00M0.02M0.00M
Gross Profit (Quarter) 0.05M0.03M0.28M0.29M0.36M0.03M0.02M0.03M0.02M0.02M0.07M0.02M0.02M0.02M0.03M0.05M0.01M0.15M0.01M
Operating items
Research & Development (Quarter) 0.11M0.17M0.18M0.74M0.41M0.23M0.23M0.22M0.35M
Selling, General & Administrative (Quarter) 1.62M0.30M0.22M0.39M0.48M0.41M0.34M0.48M1.95M-0.87M0.48M0.60M1.80M1.35M0.93M0.69M0.78M1.04M0.79M
Other Operating Expenses (Quarter) 0.22M0.31M0.43M0.35M0.17M0.34M0.46M0.42M0.49M2.51M0.55M0.55M0.56M0.81M0.70M0.76M1.35M1.30M0.99M
Operating Expenses (Quarter) 1.84M0.60M0.65M0.74M0.65M0.75M0.80M0.90M2.44M1.64M1.14M1.32M2.53M2.90M2.04M1.67M2.36M2.56M2.13M
Operating Income (Quarter) -1.80M-0.58M-0.38M-0.45M-0.29M-0.72M-0.78M-0.88M-2.42M-1.62M-1.07M-1.30M-2.51M-2.88M-2.01M-1.62M-2.35M-2.41M-2.12M
EBIT (Quarter) -1.80M-0.58M-0.38M-0.45M-0.29M-0.72M-0.78M-0.88M-2.42M-1.62M-1.07M-1.30M-2.51M-2.88M-2.01M-1.62M-2.35M-2.41M-2.12M
Non-operating items
Non Operating Investment Income (Quarter) 0.04M-0.01M-0.03M-0.00M160.00245.00-325.00-188.00830.00513.00-0.00M0.00M88.00
Non Operating Income (Quarter) -0.00M-0.02M-0.02M-0.02M0.16M-0.01M0.03M0.05M0.12M0.84M0.03M0.01M0.06M0.04M0.02M0.04M0.07M0.04M0.02M
Net income details
EBT (Quarter) -1.82M-0.52M-0.39M-0.45M-0.30M-0.76M-0.75M-0.82M-2.30M-0.78M-1.05M-1.28M-2.45M-2.83M-1.99M-1.58M-2.28M-2.38M-2.10M
Profit After Tax (Quarter) -1.80M-0.60M-0.39M-0.46M-0.14M-0.69M-0.71M-0.83M-2.33M-0.78M-1.04M-1.28M-2.45M-2.83M-1.99M-1.58M-2.28M-2.38M-2.10M
Income from Continuing Operations (Quarter) -1.82M-0.52M-0.39M-0.45M-0.30M-0.76M-0.75M-0.82M-2.30M-0.78M-1.05M-1.28M-2.45M-2.83M-1.99M-1.58M-2.28M-2.38M-2.10M
Consolidated Net Income (Quarter) -1.82M-0.52M-0.39M-0.45M-0.30M-0.76M-0.75M-0.82M-2.30M-0.78M-1.05M-1.28M-2.45M-2.83M-1.99M-1.58M-2.28M-2.38M-2.10M
Income towards Parent Company (Quarter) -1.82M-0.52M-0.39M-0.45M-0.30M-0.76M-0.75M-0.82M-2.30M-0.78M-1.05M-1.28M-2.45M-2.83M-1.99M-1.58M-2.28M-2.38M-2.10M
Net Income towards Common Stockholders (Quarter) -1.82M-0.52M-0.39M-0.45M-0.30M-0.76M-0.75M-0.82M-2.30M-0.78M-1.05M-1.28M-2.45M-2.83M-1.99M-1.58M-2.28M-2.38M-2.10M
Additional items
EPS (Basic) (Quarter) -0.41-0.12-0.08-0.09-0.06-0.14-0.10-0.11-0.31-0.11-0.14-0.17-0.23-0.31-0.15-0.10-0.13-0.14-0.11
EPS (Diluted) (Quarter) -0.09-0.06-0.14-0.10-0.11-0.31-0.11-0.14-0.17-0.23-0.31-0.15-0.10-0.13-0.14-0.11
Shares Outstanding (Quarter) 4.42M4.26M4.89M4.90M5.19M5.57M7.29M7.29M7.42M7.36M7.44M7.50M10.85M9.22M13.31M15.72M17.79M16.39M19.82M
Shares Outstanding (Diluted) (Quarter) 4.90M5.19M5.57M7.29M7.29M7.42M7.36M7.44M7.50M10.85M9.22M13.31M15.72M17.79M16.39M19.82M
EBITDA (Quarter) -1.80M-0.58M-0.38M-0.45M-0.29M-0.72M-0.78M-0.88M-2.42M-1.62M-1.07M-1.30M-2.51M-2.88M-2.01M-1.62M-2.35M-2.41M-2.12M
Interest Expenses (Quarter) 0.03M-0.06M0.02M0.01M0.01M0.04M0.01M0.01M0.01M0.02M0.01M0.01M0.01M-0.00M0.01M0.01M0.02M-0.06M0.03M